EP0049354A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Composition for therapeutic virucidal use, and articles and packages containing said composition
Assignee: STWB Inc
•
Filing: 1981-08-20
•
Granted: —
•
Expires: 2001-08-20
Abstract
Abstract The compositions, articles and packages for the therapeutic use in neutralizing or destroying viruses with glutaric acid are disclosed.
Inventors
- 👤 Guy Dominic Diana
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 09:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
20 words
A composition for therapeutic virucidal use characterized by a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim
20 words
A composition for therapeutic virucidal use characterized by a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
17 words
A composition according to claim 1, characterized in that the carrier is an aqueous surfactant emollient mixture.
Claim 4
Dependent Claim
15 words
A composition according to claim 1, characterized in that the carrier is an aerosol mixture.
Claim 5
Dependent Claim
15 words
A composition according to claim 1, characterized by being incorporated in pre-moistened pads or tissues.
Claim 6
Dependent Claim
23 words
A composition according to any one of claims 1 to 4, characterized by additionally containing an antimicrobially effective amount of an antimicrobial agent.
Claim 7
Dependent Claim
21 words
. A composition according to claim 5, characterized in that the antimicrobial agent is sodium benzoate, dehydroacetic acid, hexyl-resorcinol or phenoxyethanol.
Claim 8
Dependent Claim
42 words
A paper or cloth article for therapeutic virucidal use, characterized by being coated or impregnated with a virucidally effective amount of glutaric acid alone or a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim
42 words
A paper or cloth article for therapeutic virucidal use, characterized by being coated or impregnated with a virucidally effective amount of glutaric acid alone or a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim
13 words
An article according to claim 7, characterized by being a dry facial tissue.
Claim 11
Dependent Claim
83 words
9 . A package for therapeutic virucidal use, characterized by consisting glutaric acid alone, a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutical carrier or a paper or cloth article coated or impregnated with a virucidally effective amount of glutaric acid alone or a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier and a container with indicia for rhinovirucidal use of the glutaric acid, the composition or the article.
Claim 12
Dependent Claim
83 words
9 . A package for therapeutic virucidal use, characterized by consisting glutaric acid alone, a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutical carrier or a paper or cloth article coated or impregnated with a virucidally effective amount of glutaric acid alone or a composition consisting essentially of a virucidally effective concentration of glutaric acid and a pharmaceutically acceptable carrier and a container with indicia for rhinovirucidal use of the glutaric acid, the composition or the article.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.